MedTrace Logo

Perfusion and Hypoxia Evaluation in Tumors Using 18F-FDG PET/CT

NCT03373994 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2020-02-21

No results posted yet for this study

Summary

Investigators want to use 18F-FDG PET/CT imaging to reflect tumor perfusion and hypoxia.

Conditions

  • Perfusion and Hypoxia

Interventions

DIAGNOSTIC_TEST

18F-FDG PET/CT initial-time imaging

18F-FDG intravenous bolus injection after a fasting perid of more than 6 hours, simultaneously,PET/CT imaging using one bed lasting 5 minutes was underwent.

DIAGNOSTIC_TEST

18F-FDG PET/CT balanced-time imaging

18F-FDG intravenous injection after a fasting perid of more than 6 hours. After 60 minutes, PET/CT imaging using 6-7 bed positions each lasting 2 minutes was underwent.

Sponsors & Collaborators

  • Harbin Medical University

    lead OTHER

Principal Investigators

  • Baozhong Shen, Dr · The Fourth Hospital of Harbin Medical University

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-11-01
Primary Completion
2020-12-31
Completion
2020-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03373994 on ClinicalTrials.gov